Systemic hypertension

Paediatric Cardiology

Volumn , Issue , 2010, Pages 1191-1217

  Sinha, Manish D ^a   Reid, Christopher J D ^a,b  

^a EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952605583     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-3064-2.00062-X     Document Type: Chapter

References (391)

1. Beevers G., Lip G.Y.H., O'Brien E. ABC of Hypertension 2001, BMJ Books, London. 4th ed.
2. Gomez O., Prineas R.J., Rastam L. Cuffbladder width and blood pressure measurement in children and adolescents. J Hypertens 1992, 10:1235-1241.
3. O'Brien E. A century of confusion: Which bladder for accurate blood pressure measurement?. J Hum Hypertens 1996, 10:565-572.
4. Stenfield L., Dimich L., Reder R., et al. Sphygmomanometry in the pediatric patient. J Pediatr 1978, 92:934-938.
5. PerloffD., Grim C., Flack J., et al. Human blood pressure determination by sphygmomanometry. AHA Medical/Scientific Statement. Circulation 1993, 88:2460-2470.
6. Whincup P.H., Cook D.G., Shaper A.G. Blood pressure measurement in children: The importance of cuffbladder size. J Hypertens 1989, 7:845-850.
7. Lum L.G., Jones J.M.D. The effect of cuffwidth on systolic blood pressure measurements in children. J Pediatr 1977, 91:963-966.
8. Vyse T.J. Sphygmomanometer bladder length and measurements of blood pressure in children. Lancet 1987, 1:561-562.
9. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents The Fourth Report on the Diagnosis, Evaluation and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics 2004, 114:555-576.
10. Langford N.J., Ferner R.E. Toxicity of mercury. J Hum Hypertens 1999, 13:651-656.
11. O'Brien E. Replacing the mercury sphygmomanometer. BMJ 2000, 320:815-816.
12. Wright B.M., Dore C.F. A random-zero sphygmomanometer. Lancet 1970, 1:337-338.
13. O'Brien E., Mee F., Atkins N., O'Malley K. Inaccuracy of the Hawksley random zero sphygmomanometer. Lancet 1990, 336:1465-1468.
14. Conroy R.M., O'Brien E., O'Malley K., Atkins N. Measurement error in the Hawksley random zero sphygmomanometer: What damage has been done and what can we learn?. BMJ 1993, 306:1319-1322.
15. Brown W.C.B., Kennedy S., Inglis G.C., et al. Mechanisms by which the Hawksley random zero sphygmomanometer underestimates blood pressure and produces a non-random distribution of RZ values. J Hum Hypertens 1997, 11:75-93.
16. O'Brien E., Waeber B., Parati G., et al. on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring: Blood pressure measuring devices: Recommendations of the European Society of Hypertension. BMJ 2001, 322:531-536.
17. O'Brien E., Asmar R., Beilin L., et al. on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring: European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003, 21:821-848.
18. Park M.K., Menard S. Accuracy of blood pressure measurement by the Dinamap Monitor in infants and children. Pediatrics 1987, 79:907-914.
19. Whincup P.H., Bruce N.G., Cook D.G., Shaper A.G. The Dinamap 1846SX automated blood pressure recorder: Comparison with the Hawksley random zero sphygmomanometer under field conditions. J Epidemiol Community Health 1992, 46:164-169.
20. Gillman M.W., Nancy N.R., Cook R. Blood pressure measurement in childhood epidemiological studies. Circulation 1995, 92:1049-1057.
21. Park M.K., Menard S.W., Yuan C. Comparison of auscultatory and oscillometric blood pressures. Arch Pediatr Adolesc Med 2001, 155:50-53.
22. Jackson L.V., Thalange N.K.S., Cole T.J. Blood pressure centiles for Great Britain. Arch Dis Child 2007, 92:298-303.
23. Park M.K., Menard S.M. Normative oscillometric blood pressure values in the first 5 years in an office setting. Am J Dis Child 1989, 143:860-864.
24. Canzanello V.J., Jensen P.L., Schwartz G.L. Are aneroid sphygmomanometers accurate in hospital and clinic settings?. Arch Intern Med 2001, 161:729-731.
25. O'Brien E., Petrie J., Littler W., et al. The British Hypertension Society Protocol for the evaluation of blood pressure measuring devices. J Hypertens 1993, 11(Suppl 2):S43-S63.
26. Association for the Advancement of Medical Instrumentation American National Standard for Electronic or Automated Sphygmomanometers: ANSI/AAMI SP10-1993 1993, Virginia, Arlington, AAMI.
27. Available at:. http://www.dableducational.com.
28. Mitchell P.L., Parlin R.W., Blackburn H. Effect of vertical displacement of the arm on indirect blood-pressure measurement. N Engl J Med 1964, 271:72-74.
29. NHLBI (National Heart Lung and Blood Institute of the USA): Task force on blood pressure control in children. Pediatrics 1977, 59(Suppl):797-820.
30. NHLBI (National Heart Lung and Blood Institute of the USA): Task force on blood pressure control in children (second report). Pediatrics 1987, 79:1-25.
31. Scharer K. Hypertension in children and adolescents-1986. Pediatr Nephrol 1987, 1:50-58.
32. National High Blood Pressure Education Program (NHBPEP) Working Group on Hypertension Control in Children and Adolescents Update on the 1987 task force report on high blood pressure in children and adolescents: A working group report from the National High Blood Pressure Education Program. Pediatrics 1996, 98:649-658.
33. Sinaiko A.R., Gomez-Marin O., Prineas R.J. Diastolic fourth and fifth phase blood pressure in 10-to 15-year-old children: The Children and Adolescent Blood Pressure Program. Am J Epidemiol 1990, 132:647-655.
34. Elseed A.M., Shinebourne E.A., Joseph M.C. Assessment of techniques for measurement of blood pressure in infants and children. Arch Dis Child 1973, 48:932-936.
35. Whyte R.K., Elseed A.M., Fraser C.B., et al. Assessment of Doppler ultrasound to measure systolic and diastolic blood pressures in infants and young children. Arch Dis Child 1975, 50:542-544.
36. Musso N.R., Vergassola C., Barone C., Lotti G. Ambulatory blood pressure monitoring: How reproducible is it?. Am J Hypertens 1997, 10:936-939.
37. Manning G., Rushton L., Donnelly R., Millar-Craig M.W. Variability of diurnal changes in ambulatory blood pressure and nocturnal dipping status in untreated hypertensive and normotensive subjects. Am J Hypertens 2000, 13:1035-1038.
38. Wendelin-Saarenhovi M., Isoaho R., Hartiala J., et al. Long-term reproducibility of ambulatory blood pressure in unselected elderly subjects. Clin Physiol 2001, 21:316-322.
39. Mansoor G.A., McCabe E.J., White W.B. Long-term reproducibility of ambulatory blood pressure. J Hypertens 1994, 12:703-708.
40. Lurbe E., Aguilar F., Gomez A., et al. Reproducibility of ambulatory blood pressure monitoring in children. J Hypertens 1993, 11(Suppl 5):S288-S289.
41. Lurbe E., Thijs L., Redon J., et al. Diurnal blood pressure curve in children and adolescents. J Hypertens 1996, 14:41-46.
42. Stergiou G.S., Alamara C.V., Salgami E.V., et al. Reproducibility of home and ambulatory blood pressure in children and adolescents. Blood Press Monit 2005, 10:143-147.
43. Barnes V.A., Johnson M.H., Dekkers C., Treiber F.A. Reproducibility of ambulatory blood pressure in African Americans. Ethn Dis 2002, 12:S3101-S3106.
44. Krmar R.T., Berg U.B. Long-term reproducibility of routine ambulatory blood pressure monitoring in stable pediatric renal transplant recipients. Am J Hypertens 2005, 18:1408-1414.
45. Varda N.M., Gregoric A. Twenty four hour ambulatory blood pressure monitoring in infants and toddlers. Pediatr Nephrol 2005, 20:798-802.
46. Lurbe E., Cremades B., Concepcion R., et al. Factors related to quality of ambulatory monitoring in a pediatric population. Am J Hypertens 1999, 12:929-933.
47. Bald M., Kubel S., Rascher W. Validity and reliability of 24h blood pressure monitoring in children and adolescents using a portable, oscillometric device. J Hum Hypertens 1994, 8:53-63.
48. Sinha M.D., Jellett J., Booth C.J., et al. Ambulatory blood pressure (ABP) recording in children: Less frequent measurements with diary card specificity improves patient tolerability and provides comparable data. J Am Soc Nephrol 2006, F-PO419.
49. Soergel M., Kirschstein M., Busch C., et al. Oscillometric twenty four hour ambulatory blood pressure values in healthy children and adolescents. J Pediatr 1997, 130:178-184.
50. Cole T.J., Green P.J. Smoothing reference centile curves: The LMS method and penalized likelihood. Stat Med 1992, 11:1305-1319.
51. Wuhl E., Witte K., Soergel M., et al. for the German Working Group on Pediatric Hypertension: Distribution of 24-h ambulatory blood pressure in children: Normalized reference values and role of body dimensions. J Hypertens 2002, 20:1995-2007.
52. Lurbe E., Redon J., Liao Y., et al. Ambulatory blood pressure monitoring in normotensive children. J Hypertens 1994, 12:1417-1423.
53. Koch V.H., Colli A., Saito M.I., et al. Comparison between casual blood pressure and ambulatory blood pressure monitoring parameters in healthy and hypertensive adolescents. Blood Press Monit 2000, 5:281-289.
54. Sorof J.M., Portman R.J. White coat hypertension in children with elevated casual blood pressure. J Pediatr 2000, 137:493-497.
55. Stergiou G.S., Alamara C.V., Kalkana C.B., et al. Out-of-office blood pressure in children and adolescents: Disparate findings by using home or ambulatory monitoring. Am J Hypertens 2004, 17:869-875.
56. Kennedy S.E., Mackie F.E., Craig E., Kainer G. The choice of threshold limits for pediatric ambulatory blood pressure monitoring influences clinical decisions. Blood Press Monit 2006, 11:119-123.
57. Mule G., Nardi E., Andronico G., et al. Relationships between 24-h blood pressure load and target organ damage in patients with mild-to-moderate essential hypertension. Blood Press Monit 2001, 6:15-23.
58. White W.B., Dey H.M., Schulman P. Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild to-moderate hypertension. Am Heart J 1989, 118:782-795.
59. Lurbe E., Sorof J.M., Daniels S.R. Clinical and research aspects of ambulatory blood pressure monitoring in children. J Pediatr 2004, 144:7-16.
60. Koshy S., MacArther C., Luthra S., et al. Ambulatory blood pressure monitoring: Mean blood pressure and blood pressure load. Pediatr Nephrol 2005, 20:1484-1486.
61. Khan I.A., Gajaria M., Stephens D., Balfe J.W. Ambulatory blood pressure monitoring in children: A large center's experience. Pediatr Nephrol 2000, 14:802-805.
62. Sorof J.M., Cardwell G., Franco K., Portman R.J. Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension 2002, 39:903-908.
63. Flynn J.T. Differentiation between primary and secondary hypertension in children using ambulatory blood pressure monitoring. Pediatrics 2002, 110:89-93.
64. Dolan E., Stanton A., Thijs L., et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: The Dublin outcome study. Hypertension 2005, 46:156-161.
65. Ohkubo T., Hozawa A., Nagai K., et al. Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population: The Ohasama study. J Hypertens 2000, 18:847-854.
66. Clement D.L., De Buyzere M., De Bacquer D.A., et al. for the Office versus Ambulatory Blood Pressure (OvA) Study Investigators: Prognostic value of ambulatory blood pressure recordings in patients with treated hypertension. N Engl J Med 2003, 348:207-215.
67. Mitsnefes M.M., Kimball T.R., Daniels S.R. Office and ambulatory blood pressure elevation in children with chronic renal disease. Pediatr Nephrol 2003, 18:145-149.
68. Patzer L., Seeman T., Luck C., et al. Day and night-time blood pressure elevation in children with higher degrees of renal scarring. J Pediatr 2003, 142:117-122.
69. Bald M., Lettgen A., Wingen M., Bonzel K.E. 24 hour blood pressure monitoring in children and adolescents after recovery from hemolytic uremic syndrome. Clin Nephrol 1996, 46:50-53.
70. Sinha M.D., Walsh G., Rigby E., et al. Ambulatory blood pressure monitoring (ABPM) in paediatric renal transplant (TX) and chronic renal failure (CRF) patients: A prospective study of its clinical role. Pediatr Nephrol 2005, 20. C35:PP-011.
71. Seeman T.S., Palyzova D., Dusek J., Janda J. Reduced nocturnal blood pressure dip and sustained nighttime hypertension are specific markers of secondary hypertension. J Pediatr 2005, 147:366-371.
72. Kuwajima I., Mitani K., Miyao M., et al. Cardiac implications of the morning surge in blood pressure in elderly hypertensive patients: Relation to arising time. Am J Hypertens 1995, 8:29-33.
73. White W.B. Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate. Blood Press Monit 2001, 6:63-72.
74. Londe S. Blood pressure standards for normal children as determined under office conditions. Clin Pediatr (Phila) 1968, 7:400-403.
75. Leumann E.P., Bodmer H.G., Vetter W., Epstein F.H. Studies of blood pressure in school children of Zurich, Switzerland. International Symposium on Juvenile Hypertension. Parma June 1979.
76. Cassimos C., Varlgmis G., Karamperis S., Katsouyannopoulos V. Blood pressure in children and adolescents. Acta Paediatr Scand 1977, 66:439-443.
77. American Heart Association 2001 Heart and stroke statistical update 2002, American Heart Association, Dallas.
78. Aderele W.I., Seriki O. Hypertension in Nigerian children. Arch Dis Child 1974, 49:413-417.
79. Voors A.W., Foster T.A., Frerichs R.R., et al. Studies of blood pressure in children, ages 5-14 years, in a total biracial community: The Bogalusa Heart Study. Circulation 1976, 54:319-327.
80. Voors A.W., Webber L.S., Frerichs R.R., Berenson G.S. Body weight and body mass as determinants of basal blood pressure in children: The Bogalusa Heart Study. Am J Epidemiol 1977, 106:101-108.
81. Hohn A.R., Dwyer K.M., Dwyer J.H. Blood pressure in youth from four ethnic groups: The Pasadina Prevention Project. J Pediatr 1994, 125:368-373.
82. Webber L.S., Harsha D.W., Phillips G.T., et al. Cardiovascular risk factors in Hispanic, white and black children: The Brooks County and Bogalusa Heart Studies. Am J Epidemiol 1991, 133:704-714.
83. Harshfield G.A., Alpert B.S., Pulliam D.A., et al. Ambulatory blood pressure recordings in children and adolescents. Pediatrics 1994, 94:180-184.
84. Gutgesell M., Terrell G., Labarthe D. Pediatric blood pressure: Ethnic comparison in a primary care center. Hypertension 1981, 3:39-47.
85. Alpert B.S., Fox M.E. Racial aspects of blood pressure in children and adolescents. Pediatr Clin North Am 1993, 40:13-22.
86. Londe S., Gollub S.W., Goldring D. Blood pressure in black and white children. J Pediatr 1977, 90:93-95.
87. Park M.K., Menard S.W., Yuan C. Comparison of blood pressure in children from three ethnic groups. Am J Cardiol 2001, 87:1305-1308.
88. Kilcoyne M.M., Richter R.W., Alsop P.A. Adolescent hypertension. 1. Detection and prevalence. Circulation 1974, 50:758-764.
89. Roberts J, Maurer K: Blood pressure levels of persons 6-74 years, United States, 1971-74. Vital and Health Statistics 1977; series 11, No. 203. DHEW Publ. No. (HRA) 78-1648. Washington, DC: U.S. Government Printing Office, 1977.
90. Harshfield G.A., Alpert B.S., Pulliam D.A. Renin-angiotensin-aldosterone system in healthy subjects aged ten to eighteen years. J Pediatr 1993, 122:563-567.
91. Burlage S.R. The blood pressure and heart rate in girls during adolescence. Am J Physiol 1923, 64:252-284.
92. Sorof J., Daniels S. Obesity hypertension in children: A problem of epidemic proportions. Hypertension 2002, 40:441-447.
93. Londe S., Goldring D., Gollub S.W., Hernandez A. Blood pressure and hypertension in children: Studies, problems and perspectives. Juvenile Hypertension. 1977, 13-23. Raven Press, New York. M.I. New, L.S. Levine (Eds.).
94. Levine L.S., Lewy J.E., New M.I. Hypertension in high school students, evaluation in New York City. N Y State J Med 1976, 76:40-44.
95. Maxwell M.H., Waks A.U., Schroth P.C., et al. Error in blood pressure measurement due to incorrect cuffsize in obese patients. Lancet 1982, 33-35.
96. Florey C.V., Uppal S., Lowy C. Relation between blood pressure, weight, and plasma sugar and serum insulin levels in school, children aged 9-12 years in Westland, Holland. BMJ 1976, i:1368-1371.
97. de Swiet M., Fayers P., Shinebourne E.A. Value of repeated blood pressure measurements in children-the Brompton study. BMJ 1980, 280:1567-1568.
98. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC7 Report. JAMA 2003, 289:2560-2572.
99. Reichert H., Lindinger A., Frey O., et al. Ambulatory blood pressure monitoring in healthy school children. Pediatr Nephrol 1995, 9:282-286.
100. Weng K.P., Hsieh K.S., Huang S.H., Lin C.C. Oscillometric ambulatory blood pressure values in healthy children. Acta Paediatr Taiwan 2002, 43:15-20.
101. Krull F., Buck T., Offner G., Brodehl J. Twenty-four hour blood pressure monitoring in healthy children. Eur J Pediatr 1993, 152:555-558.
102. Reusz G.S., Hobor M., Tulassay T., et al. 24 hour blood pressure monitoring in healthy and hypertensive children. Arch Dis Child 1994, 70:90-94.
103. Harshfield G.A., Treiber F.A. Racial differences in ambulatory blood pressure monitoring-derived 24 h patterns of blood pressure in adolescents. Blood Press Monit 1999, 4:107-110.
104. Profant J., Dimsdale J.E. Race and diurnal blood pressure patterns: A review and meta-analysis. Hypertension 1999, 33:1099-1104.
105. Harshfield G.A., Treiber F.A., Wilson M.E., et al. A longitudinal study of ethnic differences in ambulatory blood pressure patterns in youth. Am J Hypertens 2002, 15:525-530.
106. Wang X., Poole J.C., Treiber F.A., et al. Ethnic and gender differences in ambulatory blood pressure trajectories: Results from a 15-year longitudinal study in youth and young adults. Circulation 2006, 114:2780-2787.
107. Alpert B.S., Daniels S.R. Twenty-four-hour ambulatory blood pressure monitoring: Now that technology has come of age-we need to catch up. J Pediatr 1997, 130:167-169.
108. Harshfield G.A., Wilson M.E., Treiber F.A., Alperte B.S. A comparison of ambulatory blood pressure patterns across populations. Blood Press Monit 2002, 7:265-269.
109. Hornsby J.L., Mongan P.F., Taylor A.T., Treiber F.A. 'White coat' hypertension in children. J Fam Pract 1991, 33:617-623.
110. Sorof J.M., Poffenbarger T., Franco K., Portman R. Evaluation of white coat hypertension in children: Importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension. Am J Hypertens 2001, 14:855-860.
111. Matsuoka S., Kawamura K., Honda M., Awazu M. White coat effect and white coat hypertension in pediatric patients. Pediatr Nephrol 2002, 17:950-953.
112. Lurbe E., Torro I., Alvarez V., et al. Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension 2005, 45:493-498.
113. Kavey R.W., Kveselis D.A., Atallah N., Smith F.C. White coat hypertension in childhood: Evidence for end-organ effect. J Pediatr 2007, 150:491-497.
114. Stabouli S., Kotsis V., Toumanidis S., et al. White-coat and masked hypertension in children: Association with target-organ damage. Pediatr Nephrol 2005, 20:1151-1155.
115. Matsuoka S., Awazu M. Masked hypertension in children and young adults. Pediatr Nephrol 2004, 19:651-654.
116. Rames L.K., Clarke W.R., Connor W.E., et al. Normal blood pressures and the evaluation of sustained blood pressure elevation in childhood: The Muscatine study. Pediatrics 1978, 61:245-251.
117. Falkner B., Hamstra B., Lombardo R., Shirk J. Blood pressure variability in adolescent males. Int J Paediatr Nephrol 1981, 2:177-180.
118. Beevers D.G. Blood pressures that fall on rechecking. BMJ 1982, 284:71.
119. Pickering G.W. High Blood Pressure 1968, Churchill, London, p 35. 2nd ed.
120. Julius S. Hypertension 1977, 630. McGraw Hill, New York. J. Garest, E. Kouiw, O. Kuchel (Eds.).
121. Miall W.E., Lovell H.G. Relation between change of blood pressure and age. BMJ 1967, 660-664.
122. Harlan W.R., Obermon A., Mitchell R.E., Graybiel A. Hypertension: Mechanisms and Management. 1973, 85. Grune & Stratton, New York. G. Onesti, K.E. Kim, J.H. Moyer (Eds.).
123. Peart W.S. Concepts in hypertension. The Croonian Lecture 1979. J R Coll Physicians Lond 1980, 14:141-152.
124. Bao W., Threefoot S.A., Srinivasan S.R., Berenson G.S. Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: The Bogalusa Heart Study. Am J Hypertens 1995, 8:657-665.
125. Clarke W.R., Schrott H.G., Leaverton P.E., et al. Tracking of blood lipids and cholesterol in school-age children: The Muscatine study. Circulation 1978, 58:626-634.
126. Beckett L.A., Rosner B., Roche A.F., Guo S. Serial changes in blood pressure from adolescence into adulthood. Am J Epidemiol 1992, 135:1166-1177.
127. Kuller L.H., Crook M., Almes M.J., et al. Dormont High School (Pittsburgh, Pennsylvania) blood pressure study. Hypertension 1980, 4:109-116.
128. Zinner S.H., Margolitis H.S., Rosner B., Kass E.J. Stability of blood pressure rank and urinary kallikrein concentration in childhood: An eight year follow up. Circulation 1978, 58:908-915.
129. Fuentes R.M., Notkola I.L., Shemeikka S., et al. Tracking of systolic blood pressure during childhood: A 15-year follow-up population-based family study in eastern Finland. J Hypertens 2002, 20:195-202.
130. Lauer R.M., Clark W.R. Childhood risk factors for high adult blood pressure: The Muscatine study. Pediatrics 1989, 84:633-641.
131. Rosner B., Hennekens C.H., Kass E.H., Miall W.E. Age specific correlation analysis of longitudinal blood pressure data. Am J Epidemiol 1977, 106:306-313.
132. de Swiet M., Fayers P., Shinebourne E.A. Systolic blood pressure in a population of infants in the first year of life: The Brompton study. Paediatrics 1980, 65:1028-1035.
133. Srinivasan S.R., Myers L., Berenson G.S. Changes in metabolic syndrome variables since childhood in prehypertensive and hypertensive subjects: The Bogalusa Heart Study. Hypertension 2006, 48:33-39.
134. Zinner S.H., Levy P.S., Kass E.H. Familial aggregation of blood pressure in childhood. N Engl J Med 1971, 284:401-404.
135. Biron P., Mongeau J.G. Familial aggregation of blood pressure and its components. Pediatr Clin North Am 1978, 25:29-33.
136. Biron P., Mongeau J.G., Bertrand D. Familial resemblance of body weight and weight/height in 374 homes with adopted children. J Pediatr 1977, 91:555-558.
137. Strong W.B., Miller M.D., Striplin M., Salehbhai M. Blood pressure response to isometric and dynamic exercise in healthy black children. Am J Dis Child 1978, 132:587-591.
138. Fixler D.E., Laird P.E., Browne R. Response of hypertensive adolescents to dynamic and isometric exercise stress. Paediatrics 1979, 64:579-583.
139. Nudel D.B., Goutman N., Brunson S.C., et al. Exercise performance of hypertensive adolescents. Paediatrics 1980, 65:1073-1078.
140. McEnery P.T., Davis C.A. Nonpharmacologic interventions in hypertension. Pediatr Clin North Am 1978, 25:127-136.
141. Turner M.C., Ruley E.J., Buckley K.M., Strife C.F. Blood pressure elevation in children with orthopedic immobilisation. J Pediatr 1979, 95:988-992.
142. Linshaw M.A., Stapleton F.B., Gruskin A.B., et al. Traction related hypertension in children. J Pediatr 1979, 95:994-996.
143. Ogden C.L., Flegal K.M., Carroll M.D., Johnson C.L. Prevalence and trends in overweight among U.S. children and adolescents, 1999-2000. JAMA 2002, 288:1728-1732.
144. Stamler R., Stamler J., Riedlinger W.F., et al. Weight and blood pressure findings in hypertension screening of 1 million Americans. JAMA 1978, 240:1607-1610.
145. Tremblay MS, Willms JD: Secular trends in the body mass index of Canadian children. Can Med Assoc J 2000;163:1429-1433. Erratum in Can Med Assoc J 2001;164:970.
146. Paradis G., Lambert M., O'Loughlin J., et al. Blood pressure and adiposity in children and adolescents. Circulation 2004, 110:1832-1838.
147. Lobstein T., Baur L., Uauy R. International Obesity Task Force: Obesity in children and young people: A crisis in public health. Obes Rev 2004, 5(Suppl 1):S4-S104.
148. Genovesi S., Giussani M., Pieruzzi F., et al. Results of blood pressure screening in a population of school-aged children in the province of Milan: Role of overweight. J Hypertens 2005, 23:493-497.
149. Chiolero A., Madeleine G., Gabriel A., et al. Prevalence of elevated blood pressure and association with overweight in children of a rapidly developing country. J Hum Hypertens 2007, 21:120-127.
150. Lurbe E., Invitti C., Torro I., et al. The impact of the degree of obesity on the discrepancies between office and ambulatory blood pressure values in youth. J Hypertens 2006, 24:1557-1564.
151. Freedman D.S., Dietz W.H., Srinivasan S.R., Berenson G.S. The relation of overweight to cardiovascular risk factors among children and adolescents: The Bogalusa Heart Study. Pediatrics 1999, 103:1175-1182.
152. Berenson G.S., Srinivasan S.R., Bao W., et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998, 338:1650-1656.
153. Freedman D.S., Khan L.K., Dietz W.H., et al. Relationship of childhood obesity to coronary heart disease risk factors in adulthood: The Bogalusa Heart Study. Pediatrics 2001, 108:712-718.
154. Brion M.A., Ness A.R., Smith G.D., Leary S.D. Association between body composition and blood pressure in a contemporary cohort of 9-year-old children. J Hum Hypertens 2007, 21:283-290.
155. Mamun A.A., Lawlor D.A., O'Callaghan M.J., et al. Effect of body mass index changes between ages 5 and 14 on blood pressure at age 14: Findings from a birth cohort study. Hypertension 2005, 45:1083-1087.
156. Voors A.W., Webber L.S., Berenson G.S. Relationship of blood pressure levels to height and weight in children. J Cardiovasc Med 1978, 3:911-918.
157. Office of Health Economics Briefing No. 12: Hypertension 1980, Office of Health Economics, London.
158. Metropolitan Life Insurance Company Blood pressure: Insurance experience and its implications 1961, Metropolitan Life, New York.
159. Shear C.L., Burke G.L., Freedman D.S., et al. Designation of children with high blood pressure-considerations on percentile cut points and subsequent high blood pressure: The Bogalusa Heart Study. Am J Epidemiol 1987, 125:73-84.
160. Sorof J.M. Systolic hypertension in children: Benign or beware?. Pediatr Nephrol 2001, 16:517-525.
161. Burke G.L., Ardila R.A., Culpepper W.S., et al. Blood pressure and echocardiographic measures in children: The Bogalusa Heart Study. Circulation 1987, 75:106-114.
162. Daniels S.R., Meyer R.A., Liang Y.C., Bove K.E. Echocardiographically determined left ventricular mass index in normal children, adolescents and young adults. J Am Coll Cardiol 1988, 12:703-708.
163. Malcolm D.D., Burns T.L., Mahoney L.T., Lauer R.M. Factors affecting left ventricular mass in childhood: The Muscatine study. Pediatrics 1993, 92:703-709.
164. Daniels S.R., Kimball T.R., Morrison J.A., et al. Effect of lean body mass, fat mass, blood pressure, and sexual maturation on left ventricular mass in children and adolescents: Statistical, biological and clinical significance. Circulation 1995, 92:3249-3254.
165. Treiber F.A., McCaffrey F., Pflieger K., et al. Determinants of left ventricular mass in normotensive children. Am J Hypertens 1993, 6:505-513.
166. Pickering G.W. High Blood Pressure 1968, Churchill, London, p 35. 2nd ed.
167. Dillon M.J. Secondary forms of hypertension in children. Clinical Hypertension and Vascular Disease Pediatric Hypertension 2004, 159-179. Humana Press, Totowa, NJ. R.J. Portman, J.M. Sorof, J.R. Ingelfinger (Eds.).
168. Wong T.Y., Mitchell P. Hypertensive retinopathy. N Engl J Med 2004, 351:2310-2317.
169. Pries A.R., Secomb T.W., Gaehtgens P. Structural autoregulation of terminal vascular beds: Vascular adaptation and development of hypertension. Hypertension 1999, 33:153-161.
170. Balfe J.W., Rance C.P. Recognition and management of hypertensive crises in childhood. Pediatr Clin North Am 1978, 25:159-174.
171. Kilcoyne M.M., Richter R.W., Alsop P.A. Adolescent hypertension. 1. Detection and prevalence. Circulation 1974, 50:758-764.
172. Leuman E.P., et al. Blood pressure and hypertension in childhood and adolescence. Advances in Internal Medicine and Pediatrics 1979, 109-183. Springer, Berlin. P. Frick, G.A. von Harneck, G.A. Martini (Eds.).
173. Sinaiko A.R., Gomez-Marin O., Prineas R.J. Prevalence of "significant" hypertension in junior high school-aged children: The children and adolescent blood pressure program. J Pediatr 1989, 114:664-669.
174. Sorof J.M., Poffenbarger T., Franco K., et al. Isolated systolic hypertension, obesity and hyperkinetic hemodynamic states in children. J Pediatr 2002, 140:660-666.
175. Sorof J.M., Lai D., Turner J., et al. Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics 2004, 113:475-482.
176. Dube S.K., Kapoor S., Ratner H., Tunick F.L. Blood pressure studies in black children. Am J Dis Child 1975, 129:1177-1180.
177. Pistulkova H., Blaha J., Skodova I. Prevalence of hypertension in children and adolescents. Cor Vasa 1976, 18:237-240.
178. Gill D.G. Blood pressure in Dublin school children. Ir Med J Sci 1977, 146:255-259.
179. Strunge P., Trostmann A.F. Serum lipids, blood pressure, skin folds, height and weight in 580 Danish school children aged 8-17 years. Dan Med Bull 1978, 25:166-171.
180. Gill D.G., Mendes de Costa B., Cameron J.S., et al. Analysis of 100 children with severe and persistent hypertension. Arch Dis Child 1976, 51:951-956.
181. Uhari M., Saukkonen A.L., Koskimies O. Central nervous system involvement in severe arterial hypertension of childhood. Eur J Paediatr 1979, 132:141-146.
182. Trompeter R.S., Smith R.L., Neville B.C.R., Chantler C. Neurological complications of arterial hypertension in children. Arch Dis Child 1982, 57:913-917.
183. Hulse J.A., Taylor D.S.I., Dillon M.J. Blindness and paraplegia in severe childhood hypertension. Lancet 1979, 553-556.
184. Garg R.K. Posterior leukoencephalopathy syndrome. Postgrad Med J 2001, 77:24-28.
185. Das G., Laddu A. Cocaine: Friend or foe? 2. Int J Clin Pharmacol Ther Toxicol 1993, 31:489-496.
186. Horn P.T. Persistent hypertension after prenatal cocaine exposure. J Pediatr 1992, 121:288-291.
187. Deshpande P.V., Gilbert R.D., Williams J., et al. Hypertension: A cause of growth impairment. J Hum Hypertens 2002, 16:363-366.
188. Giordano U., Turchetta A., Giannotti A., et al. Exercise testing and 24-hour ambulatory blood pressure monitoring in children with Williams syndrome. Pediatr Cardiol 2001, 22:509-511.
189. Radford D.J., Pohlner P.G. The middle aortic syndrome: An important feature of Williams' syndrome. Cardiol Young 2000, 10:597-602.
190. Nathwani N.C., Unwin R., Brook C.G., Hindmarsh P.C. Blood pressure and Turner syndrome. Clin Endocrinol 2000, 52:363-370.
191. Flynn J.T. Neonatal hypertension: Diagnosis and management. Pediatr Nephrol 2000, 14:332-341.
192. Laird W.P., Fixler D.E. Left ventricular hypertrophy in adolescents with elevated blood pressure: Assessment by chest roentgenography, electrocardiography, and echocardiography. Pediatrics 1981, 69:255-259.
193. Litwin M., Niemirska A., Sladowska J., et al. Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension. Pediatr Nephrol 2006, 21:811-819.
194. Hain S.F. Renal imaging. Clin Medicine 2006, 6:244-248.
195. Manger W.M. Diagnosis and management of pheochromocytoma-recent advances and current concepts. Kidney Int 2006, 70(Suppl 104S):S30-S35.
196. Manger W.M., Eisenhofer G. Pheochromocytoma: Diagnosis and management update. Curr Hypertens Rep 2004, 6:477-484.
197. Gillman M.W., Cook N.R., Rosner B., et al. Identifying children at high risk for the development of essential hypertension. J Pediatr 1993, 122:837-846.
198. Houtman P.N., Dillon M.J. Routine measurement of blood pressure in schoolchildren. Arch Dis Child 1991, 66:567-568.
199. Hypertension in childhood. [Editorial.]. Lancet 1979, 2:833-834.
200. Zubrow A.B., Hulman S., Kushner H., Falkner B. Determinants of blood pressure in infants admitted to neonatal intensive care units: A prospective multicenter study. Philadelphia Neonatal Blood Pressure Study Group. J Perinatol 1995, 15:470-479.
201. Hegyi T., Anwar M., Carbone M.T., et al. Blood pressure ranges in premature infants. 2. The first week of life. Pediatrics 1996, 97:336-342.
202. Lee J., Rajadurai V.S., Tan K.W. Blood pressure standards for very low birthweight infants during the first day of life. Arch Dis Child Fetal Neonatal Ed 1999, 81:F168-F170.
203. Nuntnarumit P., Yang W., Bada-Ellzey H.S. Blood pressure measurements in the newborn. Clin Perinatol 1999, 26:981-996.
204. Engle W.D. Blood pressure in the very low birth weight neonate. Early Hum Dev 2001, 62:97-130.
205. Batton B., Batton D., Riggs T. Blood pressure during the first 7 days in premature infants born at postmenstrual age 23 to 25 weeks. Am J Perinatol 2007, 24:107-115.
206. Kent A.L., Kecskes Z., Shadbolt B., Falk M.C. Normative blood pressure data in the early neonatal period. Pediatr Nephrol 2007, 22:1335-1341.
207. Pejovic B., Peco-Antic A., Marinkovic-Eric J. Blood pressure in non-critically ill preterm and full-term neonates. Pediatr Nephrol 2007, 22:249-257.
208. Adelman R.D. The hypertensive neonate. Clin Perinatol 1988, 15:567-585.
209. Adelman R.D. Neonatal hypertension. Pediatr Clin North Am 1978, 25:99-110.
210. Jackson J.C., Truog W.E., Watchko J.F., et al. Efficacy of thromboresistant umbilical artery catheters in reducing thrombosis and related complications. J Pediatr 1987, 110:102-105.
211. Marks S.D., Massicotte M.P., Steele B.T., et al. Neonatal renal venous thrombosis: Clinical outcomes and prevalence of prothrombotic disorders. J Pediatr 2005, 146:811-816.
212. Abman S.H., Warady B.A., Lum G.M., Koops B.L. Systemic hypertension in infants with bronchopulmonary dysplasia. J Pediatr 1984, 104:928-931.
213. Rahill W.J., Molteni A., Hawkin K.M., et al. Hypertension and narrowing of the renal arteries in infancy. J Pediatr 1974, 84:39-44.
214. Cole B.R., Conley S.B., Stapleton F.B. Polycystic kidney disease in the first year of life. J Pediatr 1987, 111:693-699.
215. Boedy R.F., Goldberg A.K., Howell C.G., et al. Incidence of hypertension in infants on extracorporeal membrane oxygenation. J Pediatr Surg 1990, 25:258-261.
216. Friedman A.L., Hustead V.A. Hypertension in babies following discharge from a neonatal intensive care unit: A 3-year follow-up. Pediatr Nephrol 1987, 1:30-34.
217. Caplan M.S., Cohn R.A., Langman C.B., et al. Favorable outcome of neonatal aortic thrombosis and renovascular hypertension. J Pediatr 1989, 115:291-295.
218. Mocan H., Beattie T.J., Murphy A.V. Renal venous thrombosis in infancy: Long-term follow-up. Pediatr Nephrol 1991, 5:45-49.
219. Messerli F.H., Williams B., Ritz E. Essential hypertension. Lancet 2007, 370:591-603.
220. Dahl L.K., Schakow E. Effects of chronic excess salt ingestion: Experimental hypertension in the rat. Can Med Assoc J 1964, 90:155-160.
221. Wiggins R.C., Basar I., Slater J.D.H. Effect of arterial pressure and inheritance on the normal sodium excretory capacity in normal young men. Clin Sci Mol Med 1978, 54:639-647.
222. Staessen J.A., Wang J., Bianchi G., Birkenhager W.H. Essential hypertension. Lancet 2003, 361:1629-1641.
223. Sinaiko A., Donahue R.P., Jacobs D.R., Prineas R.J. Relation of weight and rate of increase in weight during childhood and adolescence to body size, blood pressure, fasting insulin, and lipids in young adults. The Minneapolis Children's Blood Pressure Study. Circulation 1999, 99:1471-1476.
224. Barker D.J.P., Winter P.D., Osmond C., et al. Weight in infancy and death from ischaemic heart disease. Lancet 1989, 334:577-580.
225. Huxley R., Neil A., Collins R. Unravelling the fetal origins hypothesis: Is there really an inverse association between birthweight and subsequent blood pressure?. Lancet 2002, 60:659-665.
226. Mackenzie H.S., Brenner B.M. Fewer nephrons at birth: A missing link in the etiology of essential hypertension?. Am J Kidney Dis 1995, 26:91-98.
227. Hostetter T.H., Olson J.L., Rennke H.G., et al. Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 1981, 241:F85-F93.
228. Shankaran S., Das A., Bauer C.R., et al. Fetal origin of childhood disease-Intrauterine growth restriction in term infants and risk for hypertension at 6 years of age. Arch Pediatr Adolesc Med 2006, 160:977-981.
229. Lurbe E., Garcia-Vicent C., Torro I., et al. First-year blood pressure increase steepest in low birthweight newborns. J Hypertens 2007, 25:81-86.
230. Johansson S., Iliadou A., Bergvall N., et al. Risk of high blood pressure among young men increases with the degree of immaturity at birth. Circulation 2005, 112:3430-3436.
231. Johnson R.J., Feig D.I., Karg D.H., Herrera-Acosta J. Resurrection of uric acid as a causal risk factor for essential hypertension. Hypertension 2005, 45:18-20.
232. Franco M.C.P., Christofalo D.M.J., Sawaya A.L., et al. Effects of low birth weight in 8-to 13-year-old children-implications in endothelial function and uric acid levels. Hypertension 2006, 48:45-50.
233. Elliott P., Stamler J., Nichols R., et al. for the Intersalt Cooperative Research Group. Intersalt revisited: Further analysis of 24 hour sodium excretion and blood pressure within and across populations. BMJ 1996, 312:1249-1253.
234. Antonios T.F.T., MacGregor G.A. Salt-more adverse effects. Lancet 1996, 348:250-251.
235. He F.J., MacGregor G.A. Importance of salt in determining blood pressure in children: Meta-analysis of controlled trials. Hypertension 2006, 48:861-869.
236. Londe S., Bourgoignie J.J., Robson A.M., Goldring D. Hypertension in apparently normal children. J Pediatr 1971, 78:569-577.
237. New M.I., Baum C.J., Levine L.S. Nomograms relating aldosterone excretion to urinary sodium and potassium in the pediatric population: Their application to the study of childhood hypertension. Am J Cardiol 1976, 37:658-666.
238. Brunner H.R., Laragh J.H., Baer L., et al. Essential hypertension: Renin aldosterone, heart attack and stroke. N Engl J Med 1972, 286:441-449.
239. Dunn M.J., Tanner R.L. Low renin hypertension. Kidney Int 1974, 5:317-325.
240. Levine L.S., Lewy J.E., New M.I. Hypertension in high school students, evaluation in New York City. N Y State J Med 1976, 76:40-44.
241. Leuman E.P., Nussberger J., Vetter W. Low renin essential hypertension in a child. Helv Paediatr Acta 1975, 30:357-363.
242. Skrabal F., Aubock J., Hortnagel H. Low sodium/high potassium diet for prevention of hypertension: Probable mechanism of action. Lancet 1981, 2:895-900.
243. Five-year findings of the hypertensive detection and follow-up program 1. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group. JAMA 1979, 242:2562-2571.
244. The Australian therapeutic trial in mild hypertension Report by the Management Committee. Lancet 1980, 1:1261-1267.
245. Oliver M.F. Does control of risk factors prevent coronary artery disease?. BMJ (Clin Res Ed) 1982, 285:1065-1066.
246. Choquette G., Ferguson R.J. Blood pressure reduction in borderline hypertensives following physical training. Can Med Assoc J 1973, 108:699-703.
247. Finerty F.A. Contraception and pregnancy in the young female hypertensive patient. Pediatr Clin North Am 1978, 25:119-126.
248. Ruley E.J. Compliance in young hypertensive patients. Pediatr Clin North Am 1978, 25:175-182.
249. Brown J.J., Lever A.F., Robertson J.I.S. Renal hypertension: Aetiology, diagnosis and treatment. Renal Disease 1979, 731-765. Blackwell, London. 4th ed. D. Black, N.F. Jones (Eds.).
250. Goldblatt H., Lynch J., Hanzal R.H., Summerville W.W. Studies on experimental hypertension 1. The production of persistent elevation of systolic blood pressure by means of renal ischaemia. J Exp Med 1934, 59:347-379.
251. Guyton A.C., Cowley A.W., Coleman T.G., et al. Post tubular versus tubular mechanisms of renal hypertension. Mechanisms of Hypertension. 1973, p 16. Excerpta Medica, Amsterdam.
252. Folkow B. The fourth Volhard lecture: Cardiovascular structural adaptation; its role in the initiation and maintenance of primary hypertension. Clin Sci Mol Med 1978, 55(Suppl 4):3S-22S.
253. Ingelfinger J.R. Renovascular disease in children. Kidney Int 1993, 43:493-505.
254. Daniels S.R., Loggie J.M., McEnery P.T., Towbin R.B. Clinical spectrum of intrinsic renovascular hypertension in children. Pediatrics 1987, 80:698-704.
255. Deal J.E., Snell M.F., Barratt T.M., Dillon M.J. Renovascular disease in childhood. J Pediatr 1992, 121:378-384.
256. Hiner L.B., Falkner B. Renovascular hypertension in children. Pediatr Clin North Am 1993, 40:123-140.
257. Youngberg S.P., Sheps S.G., Strong C.G. Fibromuscular disease of the renal arteries. Med Clin North Am 1977, 61:623-641.
258. Slovit D.P., Olin J.W. Fibromuscular dysplasia. N Engl J Med 2004, 350:1862-1871.
259. Pannier-Moreau I., Grimbert P., Fiquet-Kempf B., et al. Possible familial origin of multifocal renal artery fibromuscular dysplasia. J Hypertens 1997, 15:1797-1801.
260. Bofinger A., Hawley C., Fisher P., et al. Polymorphisms of the renin-angiotensin system in patients with multifocal renal arterial fibromuscular dysplasia. J Hum Hypertens 2001, 15:185-190.
261. Aurell M. Fibromuscular dysplasia of the renal arteries. BMJ 1979, i:1180-1181.
262. Pesonen E., Koskimies O., Rapola J., Jaaskelainen J. Fibromuscular disease in a child with generalised arterial disease. Acta Paediatr Scand 1980, 69:563-566.
263. McTaggart S.J., Gulati S., Walker R.G., et al. Evaluation and long-term outcome of pediatric renovascular hypertension. Pediatr Nephrol 2000, 14:1022-1029.
264. Lee D.H., Sapire D., Markowitz R., Gruskin A. Radiation injury to abdominal aorta and iliac artery sustained in infancy. South Afr Med J 1976, 50:658-660.
265. Juncos L.I., Deture F.A., Walker R.D., Maclovsky M.L. Renin dependent renovascular hypertension in an infant with abdominal aortic atresia. Urology 1976, 7:628-631.
266. Wiggelinkhuizen J., Cremin B.J. Takayusu arteritis and renovascular hypertension in children. Pediatrics 1978, 62:209-217.
267. Morrison R., Milner L.S., Jacobs D., et al. The role of mycobacteria in Takayasu's arteritis (TA). Kidney Int 1989, 35:913.
268. Milner L.S., Jacobs D.W., Thomson P.D., et al. Management of severe hypertension in childhood Takayasu's arteritis. Pediatr Nephrol 1991, 5:38-41.
269. Nastri M.V., Baptista L.P., Baroni R.H., et al. Gadolinium-enhanced three-dimensional MR angiography of Takayasu arteritis. Radiographics 2004, 24:773-786.
270. Andrews J., Mason J.C. Takayasu's arteritis-recent advances in imaging offer promise. Rheumatology 2007, 46:6-15.
271. Shelhamer J.H., Volkman D.J., Parrillo J.E., et al. Takayasu's arteritis and its therapy. Ann Intern Med 1985, 103:121-126.
272. Kerr G.S., Hallahan C.W., Giordano J., et al. Takayasu arteritis. Ann Intern Med 1994, 120:919-929.
273. Chantler C., Joseph M.C., Davies H. Cardiovascular and other associations of infantile hypercalcaemia. Guy's Hospital Reports 1966, 115:221-241.
274. Bennett S.P., Levine L.S., Siegal E.J., et al. Juvenile hypertension caused by overproduction of renin within a renal segment. J Pediatr 1974, 84:689-695.
275. Vidt D.G. Hypertension induced by irradiation to the kidney. Arch Intern Med 1977, 137:840-841.
276. Arneill G.G., MacDonald A.M., Murphy A.V., Sweet E.M. Renal venous thrombosis. Clin Nephrology 1973, 1:119-131.
277. Kliewer M.A., Tupler R.H., Carroll B.A., et al. Renal artery stenosis: Analysis of Doppler waveform parameters and tardus-parvus pattern. Radiology 1993, 189:779-787.
278. Postma C.T., Bijlstra P.J., Rosenbusch G., Thien T. Pattern recognition of loss of early systolic peak by Doppler ultrasound has a low sensitivity for the detection of renal artery stenosis. J Hum Hypertens 1996, 10:181-184.
279. Rosendahl W., Grunert D., Schöning M. Duplex sonography of renal arteries as a diagnostic tool in hypertensive children. Eur J Pediatr 1994, 153:588-593.
280. Dillon M.J. The diagnosis of renovascular disease. Pediatr Nephrol 1997, 11:366-372.
281. Jonker G.J., Huisman R.M., de Zeeuw D. Enhancement of screening tests for renovascular hypertension by angiotensin converting enzyme inhibitors. Nephrol Dial Transplant 1993, 8:798-807.
282. Minty I., Lythgoe M.F., Gordon I. Hypertension in paediatrics: Can pre and post captopril technetium-99m dimercaptosuccinic acid scans exclude renovascular disease?. Eur J Nucl Med 1993, 20:699-702.
283. Dillon M.J., Shah V., Barratt T.M. Renal vein renin measurements in children with hypertension. BMJ 1978, 2:168-170.
284. Dillon M.J. Renin angiotensin aldosterone system. Eur J Clin Pharmacol 1980, 18:105-108.
285. Goonasekera C.D.A., Shah V., Wade A.M., Dillon M.J. The usefulness of renal vein renin studies in hypertensive children: A 25-year experience. Pediatr Nephrol 2002, 17:943-949.
286. Godard C. Predictive value of renal vein renin measurements in children with various forms of renal hypertension. Helv Paediatr Acta 1977, 32:49-57.
287. Debatin J.F., Spritzer C.E., Grist T.M., et al. Imaging of renal arteries: Value of MR angiography. Am J Roentgenol 1991, 157:981-990.
288. Zhang H., Prince M.R. Renal MR angiography. Magn Reson Imaging Clin N Am 2004, 12:487-503.
289. Leiner T., Schoenberg S.O. Current status of renal artery magnetic resonance imaging: Theoretical and practical considerations and the potential role of blood-pool contrast agents. Eur Radiol 2007, 17(Suppl 2):B13-B17.
290. Rubin G.D., Dake M.F., Napel S., et al. Spiral CT of renal artery stenosis: Comparison of three-dimensional rendering techniques. Radiology 1994, 190:181-189.
291. Wells T.G., Belsha C.W. Pediatric renovascular hypertension. Curr Opin Pediatr 1996, 8:128-134.
292. Stanley J.C., Zelenock G.B., Messina L.M., Wakefield T.W. Pediatric renovascular hypertension: A thirty-year experience of operative treatment. J Vasc Surg 1995, 21:212-226.
293. Orcutt T.W., Foster J.H., Richie R.E., et al. Bilateral ex vivo renal artery reconstruction with autotransplantation. JAMA 1974, 228:493-495.
294. O'Neill J.A., Berkowitz H., Fellows K.J., Harmon C.M. Midaortic syndrome and hypertension in childhood. J Pediatr Surg 1995, 30:164-171.
295. Ellis D., Shapiro R., Scantlebury V.P., et al. Evaluation and management of bilateral renal artery stenosis in children: A case series and review. Pediatr Nephrol 1995, 9:259-267.
296. Casalini E., Sfondrini M.S., Fossali E. Two-year clinical follow-up of children and adolescents after percutaneous transluminal angioplasty for renovascular hypertension. Invest Radiol 1995, 30:40-43.
297. Tyagi S., Kaul U.A., Satsangi D.K., Arora R. Percutaneous transluminal angioplasty for renovascular hypertension in children: Initial and long-term results. Pediatrics 1997, 99:44-49.
298. Courtel J.V., Soto B., Niaudet P., et al. Percutaneous transluminal angioplasty of renal artery stenosis in children. Pediatr Radiol 1998, 28:59-63.
299. Fossali E., Signorini E., Intermite R.C., et al. Renovascular disease and hypertension in children with neurofibromatosis. Pediatr Nephrol 2000, 14:806-810.
300. Booth C., Preston R., Clark G., Reidy J. Management of renal vascular disease in neurofibromatosis type 1 and the role of percutaneous transluminal angioplasty. Nephrol Dial Transplant 2002, 17:1235-1240.
301. ShroffR., Roebuck D.J., Gordon I., et al. Angioplasty for renovascular hypertension in children: 20-year experience. Pediatrics 2006, 118:268-275.
302. Robinson N., Gedroye W., Reidy J., Saxton H.M. Renal artery stenosis in children. Clin Radiol 1991, 44:376-382.
303. König K., Gellermann J., Querfeld U., Schneider M.B. Treatment of severe renal artery stenosis by percutaneous transluminal renal angioplasty and stent implantation: Review of the pediatric experience-apropos of two cases. Pediatr Nephrol 2006, 21:663-671.
304. Kurien A., John P.R., Milford D.V. Hypertension secondary to progressive vascular neurofibromatosis. Arch Dis Child 1997, 76:454-455.
305. Dillon M.J. Investigation and management of hypertension in children. Pediatr Nephrol 1987, 1:59-68.
306. Arar M.Y., Hogg R.J., Arant B.S., Seikaly M.G. Etiology of sustained hypertension in children in the southwestern United States. Pediatr Nephrol 1994, 8:186-189.
307. Sinha M.D., Postlethwaite R.J. Urinary tract infections and the long-term risk of hypertension. Curr Paediatr 2003, 13:508-512.
308. Sinha M.D., Gibson P., Kane T., Lewis M.A. Accuracy of ultrasonic detection of renal scarring in different centres using DMSA as the gold standard. Nephrol Dial Transplant 2007, 22:2213-2216.
309. Chapman W.S., Douglas A.S. Hypertension and unilateral hydronephrosis in children successfully treated by pyeloplasty, report of two cases. J Paediatr Surg 1975, 10:281-282.
310. Carella J.A., Silbeir I. Hyperreninaemic hypertension in an infant secondary to pelviureteric junction obstruction treated successfully by surgery. J Pediatr 1976, 88:987-989.
311. Farnham S.B., Adams M.C., Brock J.W., Pope J.C.I.V. Pediatric urological causes of hypertension. J Urology 2005, 173:697-704.
312. Powell H.R., Rotenberg E., Williams A.L., McCredie D.A. Plasma renin activity in acute post streptococcal glomerulonephritis and the haemolytic uraemic syndrome. Arch Dis Child 1974, 49:802-807.
313. Rodriguez-Iturbe B., Colic D., Parra G., Gutkowska J. Atrial natriuretic factor in the acute nephritic and nephrotic syndromes. Kidney Int 1990, 38:512-517.
314. Rahill W.J., Rubin M.I. Hypertension in infantile polycystic renal disease: The importance of early recognition and treatment of severe hypertension in polycystic renal disease. Clin Pediatr (Phila) 1972, 11:232-235.
315. Tee J.B., Acott P.D., McLellan D.H., Crocker J.F. Phenotypic heterogeneity in pediatric autosomal dominant polycystic kidney disease at first presentation: A single-center, 20-year review. Am J Kidney Dis 2004, 43:296-303.
316. Sheth K.H., Tang T.T., Blaedel M.E., Good T.A. Polydypsia, polyuria and hypertension associated with renin secreting Wilms' tumour. J Paediatr 1978, 92:921-924.
317. Brown J.J., Fraser R., Lever A.F., et al. Hypertension and secondary hyperaldosteronism associated with a renin secreting renal juxtaglomerular cell tumour. Lancet 1973, 2:1228-1232.
318. McVicar M., Carman C., Chandra M., et al. Hypertension secondary to renin-secreting juxtaglomerular cell tumor: Case report and review of 38 cases. Pediatr Nephrol 1993, 7:404-412.
319. Gupta T.C., Wiggers C.J. Basic haemodynamic changes produced by aortic coarctation of different degrees. Circulation 1951, 3:17-31.
320. Beekman R.H., Katz B.P., Moorehead-Steffens C., Rocchini A.P. Altered baroreceptor function in children with systolic hypertension after coarctation repair. Am J Cardiol 1983, 52:112-117.
321. Johnson D., Perrault H., Vobecky S.J., et al. Resetting of the cardiopulmonary baroreflex 10 years after surgical repair of coarctation of the aorta. Heart 2001, 85:318-325.
322. Polson J.W., McCallion N., Waki H., et al. Evidence for cardiovascular autonomic dysfunction in neonates with coarctation of the aorta. Circulation 2006, 113:2844-2850.
323. Parker F.B., Streeten D.H., Farrell B., et al. Preoperative and postoperative renin levels in coarctation of the aorta. Circulation 1982, 66:513-514.
324. Ross R.D., Clapp S.K., Gunther S., et al. Augmented norepinephrine and renin output in response to maximal exercise in hypertensive coarctectomy patients. Am Heart J 1992, 123:1293-1299.
325. Rosenthal E. Coarctation of the aorta from fetus to adult: Curable condition or life long disease process?. Heart 2005, 91:1495-1502.
326. Goldring D. Treatment of the infant and child with coarctation of the aorta. Pediatr Clin North Am 1978, 25:111-119.
327. Brouwer R.M., Erasmus M.E., Ebels T., Eijgelaar A. Influence of age on survival, late hypertension, and recoarctation in elective aortic coarctation repair: Including long-term results after elective aortic coarctation repair with a follow-up from 25 to 44 years. J Thorac Cardiovasc Surg 1994, 108:525-531.
328. New M.I., Levine L.S. Adrenocortical hypertension. Pediatr Clin North Am 1978, 25:67-81.
329. Storr H.L., Chan L.F., Grossman A.B., Savage M.O. Paediatric Cushing's syndrome: Epidemiology, investigation and therapeutic advances. Trends Endocrinol Metab 2007, 18:167-174.
330. Magiakou M.A., Smyrnaki P., Chrousos G.P. Hypertension in Cushing's syndrome. Best Pract Res Clin Endocrinol Metab 2006, 20:467-482.
331. Suzuki H., Handa M., Kondo K., Saruta T. Role of renin-angiotensin system in glucocorticoid hypertension in rats. Am J Physiol 1982, 243:E48-E51.
332. Kelly J.J., Tam S.H., Williamson P.M., et al. The nitric oxide system and cortisol-induced hypertension in humans. Clin Exp Pharmacol Physiol 1998, 25:945-946.
333. Saruta T., Suzuki H., Handa M., et al. Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome. J Clin Endocrinol Metab 1986, 62:275-279.
334. Dillon M.J., Ryness J.M. Plasma renin activity and aldosterone concentration in children. BMJ 1975, 4:316-319.
335. Kowarski A.A., Migeon C.J. Aldosterone in childhood. Juvenile Hypertension. Kroc Foundation Series 8 1977, p 97. Raven Press, New York. M.I. New, L.S. Levine (Eds.).
336. Shackleton C.H. Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research. J Steroid Biochem Mol Biol 1993, 45:127-140.
337. Lifton R.P., Dluhy R.G., Powers M., et al. A chimeric 11 beta-hydroxylase/aldosterone synthase gene causes GRA and human hypertension. Nature 1992, 355:262-265.
338. Rich G., Ulick S., Cook S., et al. GRA in a large kindred: Clinical spectrum and diagnosis using a characteristic biochemical phenotype. Ann Intern Med 1992, 116:813-820.
339. Yiu V.W.Y., Dluhy R.P., Lifton R.P., Guay-Woodford L.M. Low peripheral plasma renin activity as a critical marker in pediatric hypertension. Pediatr Nephrol 1997, 11:343-346.
340. Liddle G.W., Bledsoe T., Coppage W.S. A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans Assoc Am Physicians 1963, 76:199-213.
341. Aarskog D., Sta K.F., Thorsen T., Wefring K.W. Hypertension and hypokalaemic alkalosis associated with underproduction of aldosterone. Pediatrics 1967, 39:884-890.
342. Shimkets R.A., Warnock D.G., Bositis C.M., et al. Liddle's syndrome: Heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 1994, 79:407-414.
343. Hansson J.H., Nelson-Williams C., Suzuki H., et al. Hypertension caused by a truncated epithelial sodium channel gamma subunit: Genetic heterogeneity of Liddle syndrome. Nat Genet 1995, 11:76-82.
344. Schild L., Canessa C.M., Shimkets R.A., et al. A mutation in the epithelial sodium channel causing Liddle disease increases channel activity in the Xenopus laevis oocyte expression system. Proc Natl Acad Sci U S A 1995, 92:5699-5703.
345. Edwards C.R., Stewart P.M., Burt D., et al. Localisation of 11 beta-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 1988, 332:986-989.
346. Quinkler M., Bappal B., Draper N., et al. Molecular basis for the apparent mineralocorticoid excess syndrome in the Oman population. Mol Cell Endocrinol 2004, 217:143-149.
347. Morineau G., Sulmont V., Salomon R., et al. Apparent mineralocorticoid excess: Report of six new cases and extensive personal experience. J Am Soc Nephrol 2006, 17:3176-3184.
348. Gordon R.D., Geddes R.A., Pawsey C.J.K., O'Halloran M.W. Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction. Aust Ann Med 1970, 19:287-294.
349. Bruno C.M., Sciacca C., Di Prima P., et al. Gordon's syndrome: A case report. Clin Exp Hypertens 2004, 26:461-464.
350. Wilson F.H., Kahle K.T., Sabath E., et al. Molecular pathogenesis of inherited hypertension with hyperkalemia: The Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc Natl Acad Sci U S A 2003, 100:680-684.
351. Niehaus C.E., Ersser R.S., Atherden S.M. Routine laboratory investigation of urinary catecholamine metabolites in sick children. Ann Clin Biochem 1979, 16:38-43.
352. Lenders J.W., Pacak K., Walther M.M., et al. Biochemical diagnosis of pheochromocytoma: Which test is best?. JAMA 2002, 287:1427-1434.
353. Das S., Bulusu N.V., Lowe P. Primary vesical phaeochromocytoma. Urology 1983, 21:20-25.
354. Stackpole R.H., Melicow M.M., Uson A.C. Phaeochromocytoma in children: Report of 9 cases and review of the first 100 published cases with follow up studies. J Pediatr 1963, 63:315-330.
355. Boland G.W., Lee M.J. Magnetic resonance imaging of the adrenal gland. Crit Rev Diagn Imaging 1995, 36:115-174.
356. Lewis D., Dalton N., Rigden S.P.A. Phaeochromocytoma: Report of three cases. Pediatr Nephrol 1987, 1:46-49.
357. Kinney M.A., Narr B.J., Warner M.A. Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth 2002, 16:359-369.
358. Mosier H.D. Hyperthyroidism. Endocrine and Genetic Aspects of Childhood and Adolescence 1975, 285-317. WB Saunders, Philadelphia. 2nd ed. L.I. Gardner (Ed.).
359. Vasquez A.M. Nephrocalcinosis and hypertension in juvenile primary hyperparathyroidism. Am J Dis Child 1973, 125:104-106.
360. Stapleton F.B., Skoglund R.R., Daggett R.B. Hypertension associated with Guillain-Barré syndrome. Pediatrics 1978, 62:588-590.
361. Eden O.B., Sills J.A., Brown J.K. Hypertension in acute neurological diseases of childhood. Dev Med Child Neurol 1977, 19:437-445.
362. Ziegler M.G., Lake C.R., Kopin I.J. Deficient sympathetic nervous responses in familial dysautonomia. N Engl J Med 1976, 294:630-633.
363. Borromeo McGrail V., Bordiuk J.M. Keitel H: Systemic hypertension following ocular administration of 10% phenylephrine in the neonate. Pediatrics 1973, 51:1032-1036.
364. Douglas B.S., Broadfoot M.J. Hypertension in burnt children. Aust N Z J Surg 1972, 42:194-196.
365. Scholz D.A. Hypertension and hyperparathyroidism. [Editorial.] Arch Intern Med 1977, 137:1123-1124.
366. Stein J.A., Tschudy D.P. Acute intermittent porphyria: A clinical and biochemical study of 46 patients. Medicine (Baltimore) 1970, 49:1-16.
367. Engel E., Forbes A.P. Cytogenetic and clinical findings in 48 patients with congenitally defective or absent ovaries. Medicine (Baltimore) 1965, 44:135-164.
368. Kuehl I., Fricke G. Kardiovaskulare manifestations forem des Marfan Syndroms. Klinische Wochenschrift 1973, 51:1129-1142.
369. Parker J.C., Friedmann Kien A.E., Levin S. Bartter FC: Pseudoxanthoma elasticum and hypertension. N Engl J Med 1964, 271:1204-1206.
370. Loggie J.M.H. Hypertension in children and adolescents. 1. Causes and diagnostic studies. J Pediatr 1969, 74:331-355.
371. Aberg H., Michaelsson G., Walldius G. Hypertension in a patient with acrodermatitis enteropathica. Acta Paediatr Scand 1976, 65:757-759.
372. Sellers B.B. Intermittent hypertension during sickle cell crisis. J Pediatr 1978, 92:941-943.
373. Epstein M.T., Espiner E.A., Donald R.A., Hughes H. Liquorice toxicity and the renin angiotensin aldosterone axis in man. BMJ 1977, 1:209-210.
374. Friedman A., Chesney R.W., Ball D., Goodfriend T. Effective use of captopril (angiotensin I converting enzyme inhibitor) in severe childhood hypertension. J Pediatr 1981, 97:664-667.
375. Wells T., Frame V., Soffer B., et al. Enalapril Pediatric Hypertension Collaborative Study Group: A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension. J Clin Pharmacol 2002, 42:870-880.
376. Soffer B., Zhang Z., Miller K., et al. A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension. Am J Hypertens 2003, 16:795-800.
377. Kamper A.L., Strandgaard S., Leyssac P.P. Effect of enalapril on the progression of chronic renal failure: A randomized control trial. Am J Hypertens 1992, 5:423-430.
378. Louis E.J., Hunsicker L.G., Bain R.P., Rohde R.D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993, 329:1456-1462.
379. Hricik D.E., Dunn M.J. Angiotensin-converting enzyme inhibitor-induced renal failure: Causes, consequences, and diagnostic uses. J Am Soc Nephrol 1990, 1:845-858.
380. Shahinfar S., Cano F., Soffer B.A., et al. A double-blind, dose-response study of losartan in hypertensive children. Am J Hypertens 2006, 18:183-190.
381. Lubrano R., Soscia F., Elli M., et al. Renal and cardiovascular effects of angiotensin-converting enzyme inhibitor plus angiotensin II receptor antagonist therapy in children with proteinuria. Pediatrics 2006, 118:e833-e838.
382. Simonetti G.D., von Vigier R.O., Konrad M., et al. Candesartan cilexetil in children with hypertension or proteinuria: Preliminary data. Pediatr Nephrol 2007, 21:1480-1482.
383. Chandar J., Abitbol C., Montane B., Zilleruelo G. Angiotensin blockade as sole treatment for proteinuric kidney disease in children. Nephrol Dial Transplant 2007, 22:1332-1337.
384. Flynn J.T., Newburger J.W., Daniels S.R., et al. A randomized, placebo-controlled trial of amlodipine in children with hypertension. J Pediatr 2004, 145:353-359.
385. Silverstein D.M., Champoux E., Aviles D.H., Vehaskari V.M. Treatment of primary and secondary hypertension in children. Pediatr Nephrol 2006, 21:820-827.
386. Arnold W.C. Efficacy of metolazone and furosemide in children with furosemide-resistant edema. Pediatrics 1984, 74:872-875.
387. Segar J.L., Robillard J.E., Johnson K.J., et al. Addition of metolazone to overcome tolerance to furosemide in infants with bronchopulmonary dysplasia. J Pediatr 1992, 120:966-973.
388. Frick M.H., Porste P. Combined alpha and beta adrenoceptor blockade with labetalol in hypertension. BMJ 1976, 1:1046-1048.
389. Fivush B., Neu A., Furth S. Acute hypertensive crises in children: Emergencies and urgencies. Curr Opin Pediatr 1997, 9:233-236.
390. Adelman R.D., Coppo R., Dillon M.J. The emergency management of severe hypertension. Pediatr Nephrol 2000, 14:422-427.
391. Luderer J.R., Hayes A.H., Dubinsky O., Berlin C.M. Long-term administration of sodium nitroprusside in childhood. J Pediatr 1977, 91:490-491.